PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • June 30th, 2022 • Seres Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2022 Company Industry Jurisdiction
6,000,000 Shares Warrants to Purchase 2,400,000 Shares CERUS CORPORATION Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • August 20th, 2009 • Cerus Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 20th, 2009 Company Industry Jurisdiction
12,874,547 Shares Warrants to Purchase 2,574,911 Shares Genelabs Technologies, Inc. Common Stock (No Par Value) PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 26th, 2007 • Genelabs Technologies Inc /Ca • Pharmaceutical preparations
Contract Type FiledSeptember 26th, 2007 Company IndustryGenelabs Technologies, Inc., a California corporation (the “Company”), proposes, subject to the terms and conditions stated in this Placement Agency Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the investors identified therein (each, an “Investor” and collectively, the “Investors”), to issue and sell up to an aggregate of 12,874,547 shares (the “Shares”) of the Company’s common stock, no par value per share (the “Common Stock”) and warrants to purchase up to 2,574,911 shares of Common Stock (the “Warrants” and, together with the Shares, the “Securities”) in the form attached hereto as Exhibit B. The shares of Common Stock issuable upon exercise of the Warrants are hereinafter referred to as the “Warrant Shares.” The Company hereby confirms its agreement with Deutsche Bank Securities Inc. (the “Placement Agent”), as set forth below. The Securities are more fully described in the Re